Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLGW) Return on Sales (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Return on Sales for 2 consecutive years, with 1.9% as the latest value for Q4 2017.

  • Quarterly Return on Sales fell 2317.0% to 1.9% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 1.59% through Dec 2017, down 2348.0% year-over-year, with the annual reading at 24.72% for FY2025, 1429.0% up from the prior year.
  • Return on Sales for Q4 2017 was 1.9% at Bone Biologics, down from 1.91% in the prior quarter.
  • The five-year high for Return on Sales was 39.55% in Q1 2016, with the low at 1.06% in Q2 2017.